CSPC Pharmaceutical Group Limited (CHJTF)

USD 0.64

(3.23%)

Total Debt Summary of CSPC Pharmaceutical Group Limited

  • CSPC Pharmaceutical Group Limited's latest annual total debt in 2023 was 99.64 Million USD , up 19.02% from previous year.
  • CSPC Pharmaceutical Group Limited's latest quarterly total debt in 2024 Q1 was - USD , down -100.0% from previous quarter.
  • CSPC Pharmaceutical Group Limited reported annual total debt of 83.72 Million USD in 2022, up 467.56% from previous year.
  • CSPC Pharmaceutical Group Limited reported annual total debt of 14.75 Million USD in 2021, down -69.54% from previous year.
  • CSPC Pharmaceutical Group Limited reported quarterly total debt of - USD for 2024 Q1, down -100.0% from previous quarter.
  • CSPC Pharmaceutical Group Limited reported quarterly total debt of - USD for 2023 Q3, down -100.0% from previous quarter.

Annual Total Debt Chart of CSPC Pharmaceutical Group Limited (2023 - 2015)

Historical Annual Total Debt of CSPC Pharmaceutical Group Limited (2023 - 2015)

Year Total Debt Total Debt Growth
2023 99.64 Million USD 19.02%
2022 83.72 Million USD 467.56%
2021 14.75 Million USD -69.54%
2020 48.42 Million USD 79.88%
2019 26.92 Million USD 162.78%
2018 10.24 Million USD -91.89%
2017 126.27 Million USD -13.98%
2016 146.79 Million USD -22.23%
2015 188.75 Million USD 0.0%

Peer Total Debt Comparison of CSPC Pharmaceutical Group Limited

Name Total Debt Total Debt Difference
AstraZeneca PLC 28.58 Billion USD 99.651%
Bristol-Myers Squibb Company PFD CONV 2 41.46 Billion USD 99.76%
Clarus Therapeutics Holdings, Inc. 42.26 Million USD -135.742%
Novartis AG 26.34 Billion USD 99.622%
PT Kalbe Farma Tbk. 40.4 Million USD -146.613%